Enveric Biosciences, Inc. (ENVB) Stock

Enveric Biosciences, Inc. (ENVB) is a Healthcare stock trading at $1.42 (as of 2026-08-21), with a market capitalization of $6.36M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Valuation — source: SEC EDGAR (first-party)
Price$1.42
Market Cap$6.36M
Price / Book0.79
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$39.91M
Net Margin-14.0%
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.7
Industry P/E (Pharmaceutical Products)17.2
Company
SectorHealthcare
IndustryPharmaceutical Products

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • CNS Pharmaceuticals, Inc. (CNSP)
  • Xenetic Biosciences, Inc. (XBIO)
  • Apimeds Pharmaceuticals US, Inc (APUS)
  • Bolt Biotherapeutics, Inc. (BOLT)
  • Processa Pharmaceuticals, Inc. (PCSA)
  • Cadrenal Therapeutics, Inc. Common Stock (CVKD)
  • PMGC Holdings Inc. (ELAB)
  • AEON Biopharma, Inc. (AEON)
ENVB earnings history · ENVB institutional & insider holders · ENVB KPIs & operating metrics · ENVB financials · ENVB investor presentations & press releases · ENVB SEC filings · ENVB peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.